Literature DB >> 6857475

Topical therapy and the development of silver sulfadiazine.

C L Fox.   

Abstract

Topical therapy is a selective approach to the prevention and treatment of infection in burns and other surgical wounds. Effective compounds possess certain chemical and physical properties. Prerequisites include low solubility, slow absorption, nonreactivity with wound exudates, proteins and ions and ability to achieve prolonged antimicrobial activity in the wound. These compounds yield much higher levels in the zone of infection than can be achieved by diffusion into the wound after systemic administration. The wide spectrum of antibacterial activity, the low toxicity, minimal tissue reaction, ease of application suggest that topical silver sulfadiazine therapy can safely be extended to other wound infections, wound covers and certain transplant materials.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6857475

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  9 in total

Review 1.  Silver-containing alginate fibres and dressings.

Authors:  Yimin Qin
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

2.  Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.

Authors:  R W Darrell; S M Modak; C L Fox
Journal:  Trans Am Ophthalmol Soc       Date:  1984

3.  Silver-coated nylon fiber as an antibacterial agent.

Authors:  P C MacKeen; S Person; S C Warner; W Snipes; S E Stevens
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Topical silver sulphadiazine--a new drug for ocular keratomycosis.

Authors:  M Mohan; S K Gupta; V K Kalra; R B Vajpayee; M S Sachdev
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638

5.  Comparative evaluation of silver-containing antimicrobial dressings and drugs.

Authors:  Joseph J Castellano; Susan M Shafii; Francis Ko; Guillermo Donate; Terry E Wright; Rudolph J Mannari; Wyatt G Payne; David J Smith; Martin C Robson
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

6.  Di- and polynuclear silver(I) saccharinate complexes of tertiary diphosphane ligands: synthesis, structures, in vitro DNA binding, and antibacterial and anticancer properties.

Authors:  Veysel T Yilmaz; Elif Gocmen; Ceyda Icsel; Murat Cengiz; Sunde Y Susluer; Orhan Buyukgungor
Journal:  J Biol Inorg Chem       Date:  2013-10-17       Impact factor: 3.358

Review 7.  Antiseptics and disinfectants: activity, action, and resistance.

Authors:  G McDonnell; A D Russell
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

8.  Flaminal® versus Flamazine® in the treatment of partial thickness burns: A randomized controlled trial on clinical effectiveness and scar quality (FLAM study).

Authors:  Zjir M Rashaan; Pieta Krijnen; Kelly A A Kwa; Cornelis H van der Vlies; Inger B Schipper; Roelf S Breederveld
Journal:  Wound Repair Regen       Date:  2019-02-11       Impact factor: 3.617

9.  Clinical effectiveness, quality of life and cost-effectiveness of Flaminal® versus Flamazine® in the treatment of partial thickness burns: study protocol for a randomized controlled trial.

Authors:  Zjir M Rashaan; Pieta Krijnen; M Elske van den Akker-van Marle; Margriet E van Baar; Adrianus F P Vloemans; Jan Dokter; Fenike R H Tempelman; Cees H van der Vlies; Roelf S Breederveld
Journal:  Trials       Date:  2016-03-05       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.